JPMORGAN CHASE & CO - THERAPEUTICSMD INC ownership

THERAPEUTICSMD INC's ticker is and the CUSIP is 88338N206. A total of 56 filers reported holding THERAPEUTICSMD INC in Q2 2022. The put-call ratio across all filers is 2.05 and the average weighting 0.0%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of THERAPEUTICSMD INC
ValueSharesWeighting
Q3 2023$945
-26.7%
3130.0%0.00%
Q2 2023$1,289
+8.5%
313
-13.8%
0.00%
Q1 2023$1,188
+59300.0%
363
-23.7%
0.00%
Q4 2022$2
-99.9%
476
+52.1%
0.00%
Q3 2022$2,000
-50.0%
313
-6.8%
0.00%
Q2 2022$4,0003360.00%
Other shareholders
THERAPEUTICSMD INC shareholders Q2 2022
NameSharesValueWeighting ↓
Tejara Capital Ltd 355,679$1,333,7960.68%
Clearline Capital LP 419,425$1,572,8440.24%
Rubric Capital Management LP 1,192,191$4,470,7160.12%
Sixth Street Partners Management Company, L.P. 124,659$467,4710.05%
SANDERS MORRIS HARRIS LLC 33,577$125,9140.04%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 42,000$157,5000.00%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 38,042$142,6580.00%
J. Goldman & Co LP 13,562$50,8580.00%
GABELLI FUNDS LLC 31,000$116,2500.00%
OSAIC HOLDINGS, INC. 517$1,9370.00%
View complete list of THERAPEUTICSMD INC shareholders